ACOG Issues Opinion on SSRI Antidepressant Use During Pregnancy
December 1, 2006
Pharmaceutical
Washington, DC — The use of selective serotonin reuptake inhibitors (SSRIs) and selective norepinephrine reuptake inhibitors for the treatment of depression during pregnancy should be individualized based on their respective risks and benefits, according to a new Committee Opinion issued ... Read More
